KHN: Pfizer Court Fight Could Legalize Medicare Copays and Unleash ‘Gold Rush’ in Sales

The federal government frequently settles Anti-Kickback Statute enforcement matters with pharmaceutical manufacturers, including Pfizer, who pay the copays of Medicare beneficiaries using their drugs. Now Pfizer is suing the federal government to legalize the practice in the interest of patients. See this KHN article for more analysis on the case and the arguments.

This content was submitted by Robert Yates, Office of the Indiana Attorney General. If you would like to submit content or write an article for the Health Care & Life Sciences Section, please email Kara Sikorski at ksikorski@indybar.org.

Subscribe to Health Care & Life Sciences Section news here!